Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


Three Network Agencies to Handle Facial Wrinkle-Killer

By Published on .

NEW YORK (AdAge.com) -- Three days after the Food and Drug Administration approved Botox for cosmetic use, its manufacturer awarded Grey Global Group its marketing campaign for the product.

Allergan, Irvine, Calif., received the go-ahead Monday for the antiaging drug, a popular treatment for facial wrinkles. FDA approval meant Allergan was able to beging advertising the drug, which has been in use for more than a decade.

$50 million
Billings for the account are estimated at $40 million to $50 million.

Grey Worldwide will handle the consumer advertising, MediaCom will be used for media planning and buying and Grey Healthcare will implement the professional, direct and interactive marketing.

Grey beat out Publicis Groupe's Saatchi & Saatchi Healthcare, Cordiant Communications' Bates Healthworld, and Sudler and Hennessey, all New York.

Most Popular